达夫尼丁作为一种新型的多酸盐激酶抑制剂,用于对抗沙门氏菌感染

Shufang Li1, Hongfa Lv1, Shuai Yuan1

  • 1State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University, Changchun 130062, China.

概括

达夫尼丁 (DAP) 通过向聚酸盐激酶 (PPK) 酶来抑制沙门氏菌. 这种新的策略对治疗耐药沙门氏菌感染,提高生存率和减少细菌负载充满希望.